Celldex Therapeutics Inc (NASDAQ:CLDX) traded at $20.50 at close of the session on Tuesday, March 11 and made an upward move of 4.81% on its previous day’s price. Celldex Therapeutics Inc has a market cap of $1.36 billion and is expected to release its quarterly
Celldex Therapeutics Inc (NASDAQ:CLDX) shares, rose in value on Friday, March 07, with the stock price down by -3.09% to the previous day’s close as strong demand from buyers drove the stock to $20.67. Actively observing the price movement in the last trading, the stock
Celldex Therapeutics Inc (NASDAQ:CLDX) concluded the trading at $22.46 on on Friday, February 21 with a fall of -0.58% from its closing price on previous day. Considering stock’s 52-week price range provides that CLDX hit a high price of $53.18 and saw its price falling
Celldex Therapeutics Inc (NASDAQ:CLDX) shares, rose in value on Thursday, February 13, with the stock price up by 3.59% to the previous day’s close as strong demand from buyers drove the stock to $23.06. Actively observing the price movement in the last trading, the stock
Celldex Therapeutics Inc (NASDAQ:CLDX) price on Wednesday, February 05, rose 3.63% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $23.99. A look at the stock’s price movement, the close in the last trading session was $23.15, moving
Celldex Therapeutics Inc (NASDAQ:CLDX) price closed lower on Monday, February 03, and dropping -3.43% below its previous close. A look at the daily price movement shows that the last close reads $24.49, with intraday deals fluctuated between $23.37 and $24.38. The company’s 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
